Haijuan Zhang

Haijuan Zhang

Auto-generated profile, based on publicly available information

Haijuan Zhang

School of Pharmacy, Linyi University, Linyi, Shandong Province, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 December 2022 in Science Advances
Verified
Journal Article
Open access
WCWenqiang Chang
Wenqiang Chang
MZMing Zhang
Ming Zhang
XJXueyang Jin
Xueyang Jin
HZHaijuan Zhang
Haijuan Zhang
HZHongbo Zheng
Hongbo Zheng
HLHong-Xiang Lou
Hong-Xiang Lou
The global emergence of antifungal resistance threatens the limited arsenal of available treatments and emphasizes the urgent need for alternative antifungal agents. Targeting fungal pathogenic functions is an appealing alternative therapeutic strategy. Here, we show that cystathionine β-synthase (CBS), compared with cystathionine γ-lyase, is the major enzyme that synthesizes hydrogen sulfide in the pathogenic fungus Candida albicans . Deletion of CBS leads to deficiencies in resistance to oxidative stress, retarded cell growth, defective hyphal growth, and increased β-glucan exposure, which, together, reduce the pathogenicity of C. albicans . By high-throughput screening, we identified protolichesterinic acid, a natural molecule obtained from a lichen, as an inhibitor of CBS that neutralizes the virulence of C. albicans and exhibits therapeutic efficacy in a murine candidiasis model. These findings support the application of CBS as a potential therapeutic target to fight fungal infections.